Back
Pluri 10K Form
Sell
30
PLUR
Pluri
Last Price:
6.00
Seasonality Move:
-16.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PLUR News And Ratings
See the #1 stock for the next 7 days that we like better than PLUR
PLUR Financial Statistics
Sales & Book Value
| Annual Sales: | $287K |
|---|---|
| Cash Flow: | $-4.29M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.07 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -4.13000 |
|---|---|
| Net Income (TTM): | $-21.62M |
| Gross Margin: | $278K |
| Return on Equity: | -194.12% |
| Return on Assets: | -47.09% |
Pluri Earnings Forecast
Key Pluri Financial Ratios
- The Gross Profit Margin over the past 16 years for PLUR is 96.86%.
- The Selling, General & Administrative Expenses for PLUR have been equal to 4,104.18% of Gross Profit Margin.
- The Research & Development expenses have been 5,486.06% of Revenue.
- The Interest Expense is -2.98% of Operating Income.
- The Net Earning history of PLUR is -9,867.94% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 14 years.
Pluri Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PLUR |
| Website: | pluri-biotech.com |
Debt
| Debt-to-Equity Ratio: | -67.6 |
|---|---|
| Current Ratio: | 6.05 |
| Quick Ratio: | 5.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |